Tocopherol regulation of the development of responsiveness to allergen early in life

生育酚对生命早期过敏原反应性发展的调节

基本信息

  • 批准号:
    9380183
  • 负责人:
  • 金额:
    $ 55.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-23 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

The marked rise in rates of asthma over a few decades and the differences in rates among countries and in migrating populations suggest an important role of the local environment, such as diet, in development of asthma. One environmental change over the past 40 years has been an increase in d-γ-tocopherol (γ-T) in the diet. In our mechanistic studies in adult mice, a 5-fold increase in γ-T elevates eosinophilic allergic lung inflammation (175%) and airway responses whereas a 5-fold increase in another tocopherol isoform, α-T, blocks eosinophilic allergic responses (65% decrease). In mechanistic studies of signals for eosinophil recruitment in allergic asthma, we demonstrated that γ-T is an agonist and α-T is an antagonist of protein kinase C (PKC). Moreover in our studies with adult humans, a 5-fold higher plasma α-T level associates with better spirometry and a 5-fold increase in γ-T associates with lower spirometry (10 to 17% decrease in FEV1); this occurred by age 21, suggesting that early in life, tocopherol isoforms may regulate development and lung responses to environmental exposures. We propose a novel concept that early in life, α-T and γ-T regulate the development of dendritic cells (DCs) and allergic disease. Consistent with our novel concept, we demonstrated that supplementation of allergic pregnant mice with γ-T increased and α-T decreased pup allergic responses and subsets of lung CD11b+CD11c+ subsets of DCs that are critical to initiation of allergic inflammation. In addition, the inhibitory effect of α-T early in life was sustained in the pups. In vitro, γ-T increased and α-T decreased numbers of bone-marrow-derived DCs, suggesting at least a regulatory function of tocopherols on differentiation of DCs. Mechanisms for α-T and γ-T regulation of the development of DCs and allergic responses are not known. Our long term goal is to identify mechanisms for α-T and γ-T regulation of the development of DCs and allergic responses. As a step towards our long-term goal, our central HYPOTHESIS is that early in life, α-T reduces and γ-T elevates mediators that regulate 1) allergic responses and 2) CD11b+CD11c+ DC development and function during the initiation of allergic lung responses. We will test our central hypothesis with the following aims: Aim 1. Test the hypothesis that maternal α-T reduces and γ-T elevates offspring cytokines and growth factors that regulate development of DC and T cell responses to allergen early in life. Aim 2. Test the hypothesis that α-T inhibits and γ-T elevates DC PKC activity during CD11b+CD11c+ DC differentiation and activation and T cell PKC activity during DC activation of T cells. Successful completion of these studies will have a significant impact on 1) our understanding of mechanisms of α-T and γ-T regulation of DCs during development of allergies and 2) the design of clinical studies with α-T and γ-T. Furthermore, these studies will provide a basis for design of interventions that significantly impact risk for allergic disease.
几十年来哮喘发病率的显著上升以及国家和地区之间的发病率差异, 迁移人口表明当地环境的重要作用,如饮食,在发展中, 哮喘在过去的40年中,一个环境变化是d-γ-生育酚(γ-T)的增加, 饮食.在我们对成年小鼠进行的机制研究中,γ-T增加5倍会使嗜酸性粒细胞过敏性肺 炎症(175%)和气道反应,而另一种生育酚亚型α-T, 阻断嗜酸性粒细胞过敏反应(减少65%)。在嗜酸性粒细胞信号的机制研究中, 在过敏性哮喘中,我们证明γ-T是蛋白质的激动剂,α-T是蛋白质的拮抗剂 激酶C β(PKC β)。此外,在我们对成年人的研究中,血浆α-T水平升高5倍与 更好的肺功能测定和γ-T增加5倍与较低的肺功能测定相关( FEV 1);这发生在21岁,表明在生命早期,生育酚异构体可能调节发育 和肺对环境暴露的反应。我们提出了一个新的概念,即在生命早期,α-T和γ-T 调节树突状细胞(DCs)的发育和过敏性疾病。根据我们的新概念,我们 结果表明,补充γ-T可增加过敏性妊娠小鼠的仔鼠数,而补充α-T可减少仔鼠数。 过敏反应和肺CD 11b + CD 11 c + DC亚群的亚群,这些亚群对过敏反应的启动至关重要。 炎症此外,α-T在生命早期的抑制作用在幼仔中持续存在。体外,γ-T 增加和α-T减少骨髓来源的DC数量,表明至少有调节功能 对DC分化的影响。α-T和γ-T调节树突状细胞发育的机制 和过敏反应尚不清楚。我们的长期目标是确定α-T和γ-T调节的机制 树突状细胞和过敏反应的发展。为了实现我们的长期目标,我们的中央 假设在生命早期,α-T减少而γ-T升高调节1)过敏反应的介质 (2)CD 11b + CD 11 c + DC在过敏性肺反应启动过程中的发育和功能。我们将 测试我们的中心假设与以下目标:目标1。检验母体α-T降低和 γ-T升高后代细胞因子和生长因子,调节DC的发育和T细胞对 过敏原在生命早期目标二。验证α-T抑制和γ-T升高DC PKC活性的假设, CD 11b + CD 11 c + DC的分化和活化以及DC活化过程中T细胞的PKC活性。 这些研究的成功完成将对1)我们对机制的理解产生重大影响 α-T和γ-T调节DCs在变态反应发展过程中的作用; 2)α-T临床研究的设计 和γ-T。此外,这些研究将为设计显著影响风险的干预措施提供基础。 治疗过敏性疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOAN M COOK-MILLS其他文献

JOAN M COOK-MILLS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOAN M COOK-MILLS', 18)}}的其他基金

Mechanisms for initiation of food allergy early in life
生命早期发生食物过敏的机制
  • 批准号:
    10032718
  • 财政年份:
    2020
  • 资助金额:
    $ 55.9万
  • 项目类别:
Mechanisms for initiation of food allergy early in life
生命早期发生食物过敏的机制
  • 批准号:
    10653024
  • 财政年份:
    2020
  • 资助金额:
    $ 55.9万
  • 项目类别:
Mechanisms for initiation of food allergy early in life
生命早期发生食物过敏的机制
  • 批准号:
    10203801
  • 财政年份:
    2020
  • 资助金额:
    $ 55.9万
  • 项目类别:
Mechanisms for initiation of food allergy early in life
生命早期发生食物过敏的机制
  • 批准号:
    10441368
  • 财政年份:
    2020
  • 资助金额:
    $ 55.9万
  • 项目类别:
Lipid Regulation of the Development of Responsiveness to Allergen in Neonates and Infants
新生儿和婴儿对过敏原反应性发展的脂质调节
  • 批准号:
    9323656
  • 财政年份:
    2017
  • 资助金额:
    $ 55.9万
  • 项目类别:
Tocopherol regulation of the development of responsiveness to allergen early in life
生育酚对生命早期过敏原反应性发展的调节
  • 批准号:
    9981971
  • 财政年份:
    2017
  • 资助金额:
    $ 55.9万
  • 项目类别:
Tocopherol regulation of the development of responsiveness to allergen early in life
生育酚对生命早期过敏原反应性发展的调节
  • 批准号:
    10160774
  • 财政年份:
    2017
  • 资助金额:
    $ 55.9万
  • 项目类别:
Lipid Regulation of the Development of Responsiveness to Allergen in Neonates and Infants
新生儿和婴儿对过敏原反应性发展的脂质调节
  • 批准号:
    9919537
  • 财政年份:
    2017
  • 资助金额:
    $ 55.9万
  • 项目类别:
Tocopherol regulation of the development of responsiveness to allergen early in life
生育酚对生命早期过敏原反应性发展的调节
  • 批准号:
    9925738
  • 财政年份:
    2017
  • 资助金额:
    $ 55.9万
  • 项目类别:
5 -Hydroxytryptophan Regulation of Endothelial Cell Signals for Lung Inflammation
5-羟基色氨酸对肺部炎症内皮细胞信号的调节
  • 批准号:
    8711545
  • 财政年份:
    2013
  • 资助金额:
    $ 55.9万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了